ClinVar Miner

Submissions for variant NM_022970.3(FGFR2):c.1175T>G (p.Met392Arg) (rs387906677)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000493423 SCV000582486 pathogenic not provided 2015-09-14 criteria provided, single submitter clinical testing The M391R variant in the FGFR2 gene has been reported previously in the heterozygous state and presumed de novo in three unrelated fetuses described to have a perinatal lethal skeletal dysplasia called bent bone dysplasia syndrome (Merrill et al., 2012). Features in these fetuses included craniosyostosis, poorly mineralized calvarium, dysmorphic facial features, prenatal teeth, hypoplastic pubis and clavicles, osteopenia, and bent long bones (Merrill et al., 2012). Functional studies of the M391R substitutiondetermined it results in reduction of plasma membrane levels of FGFR2, thus diminishing receptor responsiveness to extracellular fibroblast growth factors (Merrill et al., 2012). Further studies of M391R revealed enhanced nuclear FGFR2 activity, with direct interaction with ribosomal RNA, ultimately promoting proliferation and reducing osteoblast differentiation in osteoprogenitor cells (Neben et al., 2014). The M391R variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The M391R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position within the transmembrane domain that is conserved across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret M391R as a pathogenic variant.
OMIM RCV000022734 SCV000044023 pathogenic Bent bone dysplasia syndrome 2012-03-09 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.